Form 4 for OMDA Omada Health, Inc.
Accepted 2026-08-05 16:59:58 ET · period of report 2026-08-03 · accession 0001610717-26-000349 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-05 16:59 | 2026-08-03 | OMDA | Duffy Sean P. | CEO, Dir | M - OptEx | $5.82 | +12.9K | 424.8K | +3% | +$75.3K |
| DT | 2026-08-05 16:59 | 2026-08-03 | OMDA | Duffy Sean P. | CEO, Dir | S - Sale+OE | $20.40 | -12.9K | 411.9K | -3% | -$264.0K |
| DT | 2026-08-05 16:59 | 2026-08-03 | OMDA | Duffy Sean P. | CEO, Dir | M - OptEx | $0.00 | -12.9K | 142.5K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-03 | M | A | 12,944 | $5.82 | 424,805 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-03 | S | D | 12,944 | $20.40 | 411,861 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F2) This transaction was executed in multiple trades at prices ranging from $20.15 to $20.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-08-03 | M | D | 12,944 | $0.00 | 142,483 | D | $5.82 · — to 2029-08-21 | 12,944 Common Stock | (F4) 100% of the shares subject to the option are fully vested and exercisable. |